Percorrer por autor "Ottenbros, Ilse"
A mostrar 1 - 2 de 2
Resultados por página
Opções de ordenação
- Plan for development of case studies - Deliverable Report AD 15.1 WP 15 - Mixtures, HBM and human health riskPublication . Kortemkamp, Andreas; Mengelers, Marcel; Vinggaard, Anne Marie; Silva, Maria João; Slamay, Remy; Vermeulen, Roel; Vlaanderen, Jelle; Ottenbros, Ilse; Viegas, Susana; Gomes, Bruno Costa; Louro, Henriqueta; Lebret, ErikThis deliverable describes the activities in task 15.3 leading up to the development of cases studies for mixture health effects and outlines the proposed case studies. The proposed case studies are: · Developmental neurotoxicity beyond polybrominated diphenylethers · Heavy metals and nephrotoxicity · Anti-androgenic chemicals and male reproductive health · Chromium (VI), nickel and polycyclic aromatic hydrocarbons and lung cancer · Addressing exposure misclassification in mixture studies The Addendum provides further details about multi-year perspective and timing, as well as detailed budgetary aspects per case study.
- A Tiered Approach for Assessing Individual and Combined Risk of Pyrethroids Using Human Biomonitoring DataPublication . Tarazona, Jose; Cattaneo, Irene; Niemann, Lars; Pedraza-Diaz, Susana; González-Caballero, MCarmen; Alba-Gonzalez, Mercedes de; Cañas, Ana; Domínguez-Morueco, Noelia; Esteban, Marta; Castano, Argelia; Borges, Teresa; Katsonouri, Andromachi; Makris, Konstantinos C.; Ottenbros, Ilse; Mol, Hans; De Decker, Annelies; Morrens, Bert; Berman, Tamar; Barnett-Itzhaki, Zohar; Probst-Hensch, Nicole; Fuhrimann, Samuel; Snoj Tratnik, Janja; Horvat, Milena; RAMBAUD, Loic; RIOU, Margaux; Schoeters, Greta; Govarts, Eva; Kolossa-Gehring, Marike; Weber, Till; Apel, Petra; Namorado, Sónia; Santonen, TiinaPyrethroids are a major insecticide class, suitable for biomonitoring in humans. Due to similarities in structure and metabolic pathways, urinary metabolites are common to various active substances. A tiered approach is proposed for risk assessment. Tier I was a conservative screening for overall pyrethroid exposure, based on phenoxybenzoic acid metabolites. Subsequently, probabilistic approaches and more specific metabolites were used for refining the risk estimates. Exposure was based on 95th percentiles from HBM4EU aligned studies (2014–2021) covering children in Belgium, Cyprus, France, Israel, Slovenia, and The Netherlands and adults in France, Germany, Israel, and Switzerland. In all children populations, the 95th percentiles for 3-phenoxybenzoic acid (3-PBA) exceeded the screening value. The probabilistic refinement quantified the risk level of the most exposed population (Belgium) at 2% or between 1–0.1% depending on the assumptions. In the substance specific assessments, the 95th percentiles of urinary concentrations in the aligned studies were well below the respective human biomonitoring guidance values (HBM-GVs). Both information sets were combined for refining the combined risk. Overall, the HBM data suggest a low health concern, at population level, related to pyrethroid exposure for the populations covered by the studies, even though a potential risk for highly exposed children cannot be completely excluded. The proposed tiered approach, including a screening step and several refinement options, seems to be a promising tool of scientific and regulatory value in future.
